\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes ERCA total of 399 proposals were submitted in response to the second and final deadline (17 September 2024) of the ERC 2024 Proof of Concept Call. In total, this represents 20% more PoC proposals to the 2024 call (728) than to the three deadlines of the 2023 call (608 proposals).
Evaluation results are expected to be communicated in January 2025.
The ERC-2025-PoC call will be published on 13 November 2024 and open for submission on the Funding & Tender opportunities Portal, with 2 cut-off dates (deadlines): 13 March 2025 and 18 September 2025 (17:00:00 time zone Brussels time).
Source: European Commission Funding and Tenders Portal
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
